Ryan Ross to Mice
This is a "connection" page, showing publications Ryan Ross has written about Mice.
Connection Strength
0.947
-
Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH). Int J Oral Sci. 2023 Oct 10; 15(1):47.
Score: 0.162
-
SHP-1 Protein Tyrosine Phosphatase Affects Early Postnatal Bone Development in Mice. Calcif Tissue Int. 2023 04; 112(4):472-482.
Score: 0.155
-
Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice. Bone. 2022 01; 154:116201.
Score: 0.141
-
Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice. J Bone Miner Res. 2020 03; 35(3):596-607.
Score: 0.124
-
HBM Mice Have Altered Bone Matrix Composition and Improved Material Toughness. Calcif Tissue Int. 2016 10; 99(4):384-95.
Score: 0.097
-
Bone Matrix Composition Following PTH Treatment is Not Dependent on Sclerostin Status. Calcif Tissue Int. 2016 Feb; 98(2):149-57.
Score: 0.094
-
An Efficient Humanized Mouse Model for Oral Anti-Retroviral Administration. Cells. 2023 03 28; 12(7).
Score: 0.039
-
Contrast-enhanced micro-computed tomography of compartment and time-dependent changes in femoral cartilage and subchondral plate in a murine model of osteoarthritis. Anat Rec (Hoboken). 2023 01; 306(1):92-109.
Score: 0.037
-
Activation of canonical Wnt signaling accelerates intramembranous bone regeneration in male mice. J Orthop Res. 2022 08; 40(8):1834-1843.
Score: 0.036
-
Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1. Cell Death Dis. 2021 Jan 25; 12(1):121.
Score: 0.034
-
Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition. JCI Insight. 2018 06 07; 3(11).
Score: 0.028